Pepinemab, a semaphorin 4D inhibitor, in combination with pembrolizumab induced formation of organized lymphoid aggregates in Phase 1b/2 study for first-line treatment of R/M HNSCC (KEYNOTE-B84)
Pembrolizumab;Pepinemab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Pepinemab, a semaphorin 4D inhibitor, in combination with pembrolizumab induced formation of organized lymphoid aggregates in Phase 1b/2 study for first-line treatment of R/M HNSCC (KEYNOTE-B84) ### Output: Pembrolizumab;Pepinemab